Finance Watch: 14 Biopharma Companies Raise $1bn From VC, Canadian Government
G2 Bio Launches With $200m, Canada Invests $164m In Resilience
Private Company Edition: More $100m-plus mega-rounds means another billion-dollar week for venture capital deals, including financings for G2 Bio, Hummingbird and Numab. Also, BioTheryX brings in $92m, Vedere launches with $77m and Eliem raises $60m two months after launching with $80m.